Newsfeeds - Spark Newswire

2 minute read

Earnings

Looking Into BioLife Solutions’s Return On Capital Employed

Today, 11:04 PM

BioLife Solutions (NASDAQ:BLFS) brought in sales totaling $31.20 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 92.73%, resulting in a loss of $2.84 million.

BLFS

2 minute read

Notable Biolife Solutions Insider Trades $971 Thousand In Company Stock

By Benzinga Insights

Today, 11:04 PM

Aby Mathew, Exec VP And Chief Scientific Off at Biolife Solutions (NASDAQ:BLFS), made a large buy and sell of company shares on September 22, according to a new SEC filing.

BLFS

1 minute read

BioLife Solutions Announces CFO Retirement

By Benzinga Newsdesk

Today, 11:04 PM

BioLife Solutions, Inc. (NASDAQ:BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the

BLFS

5 minute read

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab

By Shanthi Rexaline

Today, 11:04 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1)

ABBV

1 minute read

BioLife Solutions Files Prospectus Related To Offering Of 10.7M Shares Of Common Stock By Selling Stockholders

By Michael Horton

Today, 11:04 PM

-Reuters

BLFS

5 minute read

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical

By Shanthi Rexaline

Today, 11:04 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26)

ABSI

3 minute read

The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration

By Shanthi Rexaline

Today, 11:04 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26)

AGEN

7 minute read

Stocks That Hit 52-Week Highs On Thursday

By Benzinga Insights

Today, 11:04 PM

Before 10 a.m. ET on Thursday, 91 companies hit new 52-week highs.

5 minute read

The Daily Biotech Pulse: Early Approval For Ascendis’ Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO

By Shanthi Rexaline

Today, 11:04 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25)

ABBV

5 minute read

54 Biggest Movers From Yesterday

By Lisa Levin

Today, 11:04 PM

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares jumped 202.8% to settle at $46.33 on Wednesday after gaining over 11% on Tuesday. Regencell Bioscience recently reported partial exercise of underwriter’s over-allotment option.

ABSI